Stifel Starts Summit Therapeutics plc (SMMT) at Buy, $45 PT
Tweet Send to a Friend
(Updated - April 7, 2026 4:27 PM EDT)
Stifel analyst Dara Azar initiates coverage on Summit Therapeutics plc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Dara Azar initiates coverage on Summit Therapeutics plc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


